US drug approvals
17 approvals with a product on the US market
- Byqlovi NDA218158 · approved 4 Mar 2024
- Vevye NDA217469 · approved 30 May 2023
- Iheezo NDA216227 · approved 27 Sep 2022
- Tyrvaya NDA213978 · approved 15 Oct 2021
- Verkazia NDA214965 · approved 23 Jun 2021
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.